Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging

Bone metabolism has not been systematically studied in primary (AL) amyloidosis. Thus we prospectively evaluated bone remodeling indices in 102 patients with newly diagnosed AL amyloidosis, 35 healthy controls, 35 newly diagnosed myeloma and 40 monoclonal gammopathy of undetermined significance pati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Cancer J
Main Authors: Kastritis, E, Gavriatopoulou, M, Dimopoulos, M A, Eleutherakis-Papaiakovou, E, Kanellias, N, Roussou, M, Pamboucas, C, Toumanidis, S T, Terpos, E
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4648482/
https://ncbi.nlm.nih.gov/pubmed/26047389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2015.45
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados